Buyers probably a bit worried about the possibility of reimbursements being cut with the US debt problems. Not a sure thing, FDA has to consider the clotting issues. CEO sold a few last week interestingly enough.
HIN Price at posting:
$1.83 Sentiment: Hold Disclosure: Held